CompletedNot Applicable

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Armenia119 participantsStarted 2010-12

Plain-language summary

The purpose of this study is to evaluate the safety and efficacy of the iStent medical device that is implanted into the eye and designed to reduce eye pressure in patients with your condition.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with primary open-angle glaucoma (POAG) * Subject on two topical hypotensive medications Exclusion Criteria: * Traumatic, uveitic, neovascular, or angle closure glaucoma * Fellow eye already enrolled

What they're measuring

Mean diurnal IOP reduction of greater than or equal to 20% at month 12 vs. baseline

Timeframe: 12 Months

Trial details

NCT IDNCT01252849

SponsorGlaukos Corporation

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-10-08

View on ClinicalTrials.gov More Primary Open Angle Glaucoma (POAG) trials